143 related articles for article (PubMed ID: 16632406)
1. What are the mechanisms associated with post-ivermectin serious adverse events?
Boussinesq M; Kamgno J; Pion SD; Gardon J
Trends Parasitol; 2006 Jun; 22(6):244-6. PubMed ID: 16632406
[No Abstract] [Full Text] [Related]
2. Encephalopathy after ivermectin treatment in a patient infected with Loa loa and Plasmodium spp.
Kamgno J; Boussinesq M; Labrousse F; Nkegoum B; Thylefors BI; Mackenzie CD
Am J Trop Med Hyg; 2008 Apr; 78(4):546-51. PubMed ID: 18385346
[TBL] [Abstract][Full Text] [Related]
3. Loiasis: African eye worm.
Padgett JJ; Jacobsen KH
Trans R Soc Trop Med Hyg; 2008 Oct; 102(10):983-9. PubMed ID: 18466939
[TBL] [Abstract][Full Text] [Related]
4. Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg).
Kamgno J; Pion SD; Tejiokem MC; Twum-Danso NA; Thylefors B; Boussinesq M
Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):777-85. PubMed ID: 17531279
[TBL] [Abstract][Full Text] [Related]
5. A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
Kamgno J; Pion SD; Chesnais CB; Bakalar MH; D'Ambrosio MV; Mackenzie CD; Nana-Djeunga HC; Gounoue-Kamkumo R; Njitchouang GR; Nwane P; Tchatchueng-Mbouga JB; Wanji S; Stolk WA; Fletcher DA; Klion AD; Nutman TB; Boussinesq M
N Engl J Med; 2017 Nov; 377(21):2044-2052. PubMed ID: 29116890
[TBL] [Abstract][Full Text] [Related]
6. First case of ivermectin-induced severe hepatitis.
Veit O; Beck B; Steuerwald M; Hatz C
Trans R Soc Trop Med Hyg; 2006 Aug; 100(8):795-7. PubMed ID: 16682062
[TBL] [Abstract][Full Text] [Related]
7. Where next with Loa loa encephalopathy? Data are badly needed.
Mackenzie C; Geary T; Prichard R; Boussinesq M
Trends Parasitol; 2007 Jun; 23(6):237-8. PubMed ID: 17459773
[No Abstract] [Full Text] [Related]
8. Loa loa microfilarial periodicity in ivermectin-treated patients: comparison between those developing and those free of serious adverse events.
Kamgno J; Pion SD; Mackenzie CD; Thylefors B; Boussinesq M
Am J Trop Med Hyg; 2009 Dec; 81(6):1056-61. PubMed ID: 19996437
[TBL] [Abstract][Full Text] [Related]
9. Repurposed automated handheld counter as a point-of-care tool to identify individuals 'at risk' of serious post-ivermectin encephalopathy.
Bennuru S; Pion SD; Kamgno J; Wanji S; Nutman TB
PLoS Negl Trop Dis; 2014 Sep; 8(9):e3180. PubMed ID: 25232954
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin for treating post-ivermectin Loa-related serious adverse events?
Boussinesq M; Kamgno J; Pion SD; Mackenzie CD
Trends Parasitol; 2010 Jan; 26(1):4-5. PubMed ID: 19879192
[No Abstract] [Full Text] [Related]
11. Lymphatic filariasis.
Prescrire Int; 2008 Feb; 17(93):36. PubMed ID: 18383658
[TBL] [Abstract][Full Text] [Related]
12. [Release of Loa loa antigens after treatment with ivermectin].
Chippaux JP; Nkinin SW; Gardon-Wendel N; Ducorps M
Bull Soc Pathol Exot; 1998; 91(4):297-9. PubMed ID: 9846220
[TBL] [Abstract][Full Text] [Related]
13. Ocular findings after ivermectin treatment of patients with high Loa loa microfilaremia.
Fobi G; Gardon J; Santiago M; Ngangue D; Gardon-Wendel N; Boussinesq M
Ophthalmic Epidemiol; 2000 Mar; 7(1):27-39. PubMed ID: 10652169
[TBL] [Abstract][Full Text] [Related]
14. Rapid assessment method for prevalence and intensity of Loa loa infection.
Takougang I; Meremikwu M; Wandji S; Yenshu EV; Aripko B; Lamlenn SB; Eka BL; Enyong P; Meli J; Kale O; Remme JH
Bull World Health Organ; 2002; 80(11):852-8. PubMed ID: 12481206
[TBL] [Abstract][Full Text] [Related]
15. Post-ivermectin encephalopathy in Senegal: a case report.
Massi DG; Mansare ML; Traoré M; Ndiaye M; Diop AG; Ndiaye MM
Pan Afr Med J; 2017; 27():202. PubMed ID: 28904727
[TBL] [Abstract][Full Text] [Related]
16. [Retinal hemorrhages after ivermectin treatment for onchocerciasis in a patient with Loa loa microfilaremia].
Moussala M; Fobi G; Ongolo Zogo P; Bella Hiag LA; Bengono G; McMoli TE
J Fr Ophtalmol; 2004 Jan; 27(1):63-6. PubMed ID: 14968080
[TBL] [Abstract][Full Text] [Related]
17. Tolerability of ivermectin in gnathostomiasis.
Bussaratid V; Krudsood S; Silachamroon U; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):644-9. PubMed ID: 16124431
[TBL] [Abstract][Full Text] [Related]
18. [Nephropathy and filariasis from Loa loa. Apropos of 1 case of adverse reaction to a dose of ivermectin].
Cruel T; Arborio M; Schill H; Neveux Y; Nedelec G; Chevalier B; Teyssou R; Buisson Y
Bull Soc Pathol Exot; 1997; 90(3):179-81. PubMed ID: 9410254
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic problems in a patient with amicrofilaremic Loa loa.
Yoshikawa M; Ouji Y; Hayashi N; Moriya K; Nishiofuku M; Ishizaka S; Itoh M; Kimura E; Nakamura F; Nawa Y
J Travel Med; 2008; 15(1):53-7. PubMed ID: 18217871
[TBL] [Abstract][Full Text] [Related]
20. [Acute respiratory distress syndrome caused by tropical eosinophilic lung disease: a case in Gabon].
Chani M; Iken M; Eljahiri Y; Nzenze JR; Mion G
Med Trop (Mars); 2011 Apr; 71(2):181-2. PubMed ID: 21695880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
